Scarica l'app Stockscreener
1.85
7.96%
-0.16
Pre-mercato:
1.93
0.08
+4.32%
Precedente Chiudi:
$2.01
Aprire:
$2.09
Volume 24 ore:
7.10M
Relative Volume:
1.46
Capitalizzazione di mercato:
$171.55M
Reddito:
-
Utile/perdita netta:
$-69.31M
Rapporto P/E:
-1.4567
EPS:
-1.27
Flusso di cassa netto:
$-62.80M
1 W Prestazione:
+32.14%
1M Prestazione:
-81.79%
6M Prestazione:
-54.55%
1 anno Prestazione:
-54.66%
Intervallo 1D:
$1.84
$2.2099
Intervallo di 1 settimana:
$1.45
$2.25
Portata 52W:
$1.07
$11.46
Rezolute Inc Stock (RZLT) Company Profile
Nome
Rezolute Inc
Settore
Industria
Telefono
650-206-4507
Indirizzo
275 SHORELINE DRIVE, SUITE 500, REDWOOD CITY
Confronta RZLT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RZLT
Rezolute Inc
|
1.85 | 186.38M | 0 | -69.31M | -62.80M | -1.27 |
|
VRTX
Vertex Pharmaceuticals Inc
|
447.38 | 114.05B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
748.71 | 78.80B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
396.04 | 51.80B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
847.05 | 53.08B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
166.55 | 42.33B | 447.02M | -1.18B | -906.14M | -6.1812 |
Rezolute Inc Stock (RZLT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-11 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2025-12-11 | Downgrade | Craig Hallum | Buy → Hold |
| 2025-12-11 | Downgrade | Wedbush | Outperform → Neutral |
| 2024-11-05 | Iniziato | Wedbush | Outperform |
| 2024-08-27 | Iniziato | Guggenheim | Buy |
| 2024-07-17 | Iniziato | BTIG Research | Buy |
| 2024-06-04 | Iniziato | Craig Hallum | Buy |
| 2024-04-09 | Iniziato | Maxim Group | Buy |
| 2022-08-02 | Ripresa | Canaccord Genuity | Buy |
| 2022-06-15 | Iniziato | Cantor Fitzgerald | Overweight |
| 2021-09-08 | Iniziato | ROTH Capital | Buy |
| 2021-05-27 | Iniziato | Oppenheimer | Outperform |
| 2021-05-25 | Iniziato | H.C. Wainwright | Buy |
Mostra tutto
Rezolute Inc Borsa (RZLT) Ultime notizie
Will Rezolute Inc. stock outperform value stocks2025 Volume Leaders & AI Powered Market Trend Analysis - Bölüm Sonu Canavarı
RA Capital Acquires 9.9% Stake in Rezolute (RZLT) - GuruFocus
Rezolute shares in focus after RA Capital discloses 9.9% stake - MSN
Will Rezolute Inc. (6HV1) stock benefit from infrastructure billJuly 2025 Price Swings & Technical Entry and Exit Tips - DonanımHaber
Does Rezolute Inc. stock trade at a discount to peersJuly 2025 Action & Growth Oriented Trade Recommendations - Улправда
Is Rezolute Inc. (6HV1) stock expanding market penetrationGDP Growth & Technical Pattern Based Signals - DonanımHaber
Why analysts upgrade Rezolute Inc. stock2025 Buyback Activity & Proven Capital Preservation Methods - DonanımHaber
Is Rezolute Inc. stock positioned well for digital economy2025 Top Decliners & Risk Controlled Daily Trade Plans - Улправда
Travel Stocks: How Rezolute Inc. (6HV1) stock trades after rate cutsCEO Change & Expert Curated Trade Setup Alerts - Улправда
Shareholders Alert: Investigation Into Rezolute, Inc. (RZLT)Contact Levi & Korsinsky to Protect Your Rights - ACCESS Newswire
Rezolute: Phase 3 sunRIZE Data For Ersodetug Warrants Downgrade To Sell Rating (RZLT) - Seeking Alpha
Rezolute, Inc. (RZLT) Shares Tank 90% Amid Lead Asset Trial Failure -- Hagens Berman Investigating - PR Newswire
Insider Spends US$80k Buying More Shares In Rezolute - simplywall.st
Chief Financial Officer of Rezolute Daron Evans Buys 21% More Shares - Yahoo Finance
RZLT Stock Plummets 79% Month to Date: Here's What You Need to Know - The Globe and Mail
Levi & Korsinsky Investigates Possible Securities Fraud by Rezolute, Inc. (RZLT) - ACCESS Newswire
Top Executive Makes Bold Move in Rezolute Stock! - TipRanks
Insider Buying: Wladimir Hogenhuis Acquires Additional Shares of Rezolute Inc (RZLT) - GuruFocus
RZLT: Rezolute, Inc. Investigated for Securities Fraud; - GlobeNewswire
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute - PR Newswire
Elam Nevan C, Rezolute CEO, buys $50k in RZLT shares - Investing.com Nigeria
Rezolute, Inc. (RZLT) Under Investigation for Potential Securities Law ViolationsContact Levi & Korsinsky Today - ACCESS Newswire
Rezolute, Inc. (RZLT) Shares Tank 90% Amid Lead Asset Trial Failure -- Hagens Berman Investigating - GlobeNewswire Inc.
Elam Nevan C, Rezolute CEO, buys $50k in RZLT shares By Investing.com - Investing.com South Africa
Entry Recap: Will Rezolute Inc stock outperform value stocksInflation Watch & AI Enhanced Trading Signals - moha.gov.vn
Rezolute CFO Evans buys shares worth $79,577 By Investing.com - Investing.com Canada
Daron Evans Buys 40,000 Shares of Rezolute (NASDAQ:RZLT) Stock - MarketBeat
Rezolute (NASDAQ:RZLT) Insider Purchases 12,100 Shares - MarketBeat
Nevan Elam Increases Stake in Rezolute Inc with Recent Share Pur - GuruFocus
Rezolute’s CCO Karnawat buys $19,598 in shares By Investing.com - Investing.com Australia
Rezolute’s CCO Karnawat buys $19,598 in shares - Investing.com India
Down 81.8% in 4 Weeks, Here's Why Rezolute (RZLT) Looks Ripe for a Turnaround - sharewise.com
RZLT ALERT: Levi & Korsinsky Investigates Rezolute, Inc. on Behalf of Shareholders Who Lost Money - ACCESS Newswire
Rezolute CFO Evans buys shares worth $79,577 - Investing.com
CFO Evans Buys 45,000 ($79.6K) Of Rezolute Inc [RZLT] - TradingView — Track All Markets
Rezolute Inc. trading resumes - MSN
Rezolute, Inc. (RZLT) Shares Tank 90% Amid Lead Asset Trial Failure — Hagens Berman Investigating RZLT Investors with Losses Encouraged to Contact the Firm - Morningstar
Rezolute Inc trading halted, volatility trading pause - MSN
Rezolute downgraded to neutral from outperform at Wedbush - MSN
Rezolute (RZLT): Reassessing Valuation After sunRIZE Phase 3 Failure and Growing Legal Scrutiny - simplywall.st
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute - TMX Newsfile
Rezolute price target raised to $20 from $15 at Jefferies - MSN
Rezolute, Inc. (RZLT) Shares Tank 90% Amid Lead Asset Trial Failure -- Hagens Berman Investigating RZLT Investors with Losses Encouraged to Contact the Firm - Sahm
H.C. Wainwright Maintains Rezolute(RZLT.US) With Buy Rating, Maintains Target Price $5 - 富途牛牛
HC Wainwright Decreases Earnings Estimates for Rezolute - MarketBeat
Rezolute (RZLT) Is Down 82.7% After Phase 3 sunRIZE Failure in Congenital Hyperinsulinism Trial - Yahoo Finance
Rezolute shares collapse after phase 3 trial fails to meet main goals - MSN
Rezolute (NASDAQ:RZLT) Downgraded by Citizens Jmp to Hold - MarketBeat
Rezolute’s phase 3 study in congenital hyperinsulinism did not meet endpoints - MSN
Rezolute price target lowered to $5 from $14 at HC Wainwright - MSN
Investors Buy Large Volume of Rezolute Call Options (NASDAQ:RZLT) - MarketBeat
Rezolute Inc Azioni (RZLT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Rezolute Inc Azioni (RZLT) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| ROBERTS BRIAN KENNETH | Chief Medical Officer |
Dec 16 '25 |
Buy |
1.70 |
28,000 |
47,600 |
308,352 |
| Evans Daron | CFO |
Dec 15 '25 |
Buy |
1.77 |
40,000 |
70,640 |
415,900 |
| Evans Daron | CFO |
Dec 15 '25 |
Buy |
1.79 |
5,000 |
8,938 |
7,000 |
| Elam Nevan C | CEO |
Dec 15 '25 |
Buy |
1.59 |
32,000 |
50,880 |
641,119 |
| Karnawat Sunil Ratilal | Chief Commercial Officer |
Dec 15 '25 |
Buy |
1.62 |
12,100 |
19,599 |
71,542 |
| ROBERTS BRIAN KENNETH | Chief Medical Officer |
Jun 25 '25 |
Buy |
4.38 |
2,500 |
10,939 |
15,500 |
| Evans Daron | CFO |
Jun 24 '25 |
Buy |
4.05 |
5,000 |
20,250 |
268,900 |
| Kim Young-Jin | Director |
Jun 13 '25 |
Buy |
3.25 |
1,230,769 |
3,999,999 |
8,423,386 |
| KREHER NERISSA | Director |
Jun 13 '25 |
Buy |
3.25 |
3,076 |
9,997 |
37,576 |
| Hogenhuis Wladimir | Director |
Mar 31 '25 |
Buy |
2.92 |
6,758 |
19,733 |
84,025 |
0.31%
0.33%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):